By Type
Aimed Alliance’s New Report on AFPs: Navigating Today’s Pharmacy Benefits Efficiently, Effectively, and Ethically
The rising cost of healthcare, and prescription drugs in particular, is a source of anxiety for employers with each new…
NEW White Paper on Alternative Funding Programs
In recent years, the adoption of alternative funding programs (AFPs) among self-funded employer-sponsored plans has risen rapidly. However, few employers…
Aimed Alliance Pushes for Transparency in AI Prior Authorization Decisions
Aimed Alliance submitted written testimony regarding Washington’s Senate Bill 5395 and House Bill 1566, which aim to improve transparency and…
Aimed Alliance Advocates for Clarifications to WA Obesity Treatment Access Legislation
In February 2025, Aimed Alliance submitted a comment on Washington Senate Bill 5353, which would require health carriers to provide…
Aimed Alliance publica un nuevo recurso que explica las implicaciones de la revocación de la NBPP de 2021
A la luz de la reciente decisión del HIV + Hepatitis Policy Institute, et al. v. Health and Human Services…
Aimed Alliance & NORM Release Updated Open Enrollment Brochures
The 2024 Open Enrollment period is fast approaching! The 2024 Open Enrollment period for Medicare Advantage plans is October 15,…
Share Your Experience: Treatment Access & Your Mental Health Care
Alliance for Mental Health Care Access Survey The Alliance for Mental Health Care Access (AMHCA) is excited to share a…
New Aimed Alliance Infographic Identifies Best Practices for Migraine Management in the Workplace
A new Aimed Alliance infographic demonstrates ongoing challenges employees with migraine disease face in the workplace and best practices employers…
Aimed Alliance Receives Interim Response to FDA Citizen Petition
On August, 28, 2024, Aimed Alliance received an interim response from the Food and Drug Administration regarding its Citizen Petition…
Aimed Alliance to Speak at the Ohio Rare Disease Summit
Aimed Alliance’s Counsel, Ashira Vantrees, will be speaking to employers at the Ohio Rare Disease Summit on “Managing Prescription Drug…
